Trial Profile
Effect of Caduet and TLC Intervention on Metabolic Parameters
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Aug 2021
Price :
$35
*
At a glance
- Drugs Amlodipine/atorvastatin (Primary)
- Indications Metabolic syndrome
- Focus Therapeutic Use
- 24 Apr 2018 New trial record